AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03274219 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: bb21217
Description: autologous T cells transduced ex-vivo with anti-BCMA CAR lentiviral vector encoding the chimeric antigen receptor (CAR) targeted to human BCMA, suspended in cryopreservative solution
Study NCT02780622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oseltamivir
Description: Oseltamivir 75 mg orally, twice daily for 4 days and once on Day 5.
Study NCT02780622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Warfarin
Description: Warfarin once daily, at a dose determined through titration by participants' usual hematologist.
Study NCT00715572 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: thyroxine
Description: monotherapy with thyroxine
Study NCT00715572 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: thyroxine and triiodothyronine
Description: combination with thyroxine and triiodothyronine
Study NCT01100047 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD5069
Description: Oral suspension
Study NCT01100047 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral suspension
Study NCT01453478 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1325756
Description: CXCR2 antagonist
Study NCT04381260 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: There is no intervention for patients included in this group as this is a retrospective data registry only.
Study NCT04381260 — intervention group
Intervention type: OTHER
Intervention: Interview
Description: Key Informant Interview
Study NCT04381260 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: Stakeholder survey
Study NCT04426344 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ensoETM device
Description: Core warming will be performed using standard technique per instructions for use for the esophageal heat transfer device. The esophageal heat transfer device will be set to 42°C temperature after initial placement, and maintained at 42°C for the duration of treatment. It is expected that patient temperature will increase from baseline by 1°C to 2°C, but due to ongoing heat loss from the patient, the expected maximum patient temperature is below 39°C. The time course of illness of COVID-19 is such that most patients no longer have fever by the time of mechanical ventilation.\[41\] If patient temperature increases above this range and reaches 39.8°C, the device will be set to an operating temperature of 40°C, thereby preventing any further increase in patient temperature (ambient heat loss precludes patient from reaching device operating temperature).
Study NCT02042638 — intervention group
Intervention type: DRUG
Intervention: hCG 1500 IU three times a week
Study NCT02042638 — intervention group
Intervention type: DRUG
Intervention: Pregnyl (hCG) ampule 1500 IU/three times a week
Study NCT02692950 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Honor My Decisions Advance Care Planning Video
Description: Honor My Decisions is a commercial computer application which allows a person to record a video of his/her advanced care planning and legacy information.
Study NCT02692950 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Post-video questionnaire
Description: Questions regarding the video process, changes to previous answers and reaction received by others viewing the video
Study NCT03032874 — intervention group
Intervention type: PROCEDURE
Intervention: Colonoscopy
Description: They all had screening colonoscopy
Study NCT02049710 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Seventeen Days
Description: Interactive video includes highlighting salience of active choices in sexual decision making, modeling different responses to sexual situations, cognitive rehearsal of preventive behaviors, and information about hormonal and non-hormonal contraception
Study NCT02049710 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Driving Skills for Life
Description: Interactive video includes guidance and practice for safe driving techniques, driver and car care tips, an eco-driving learning module, and interactive driving games.
Study NCT01370603 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atorvastatin
Description: 40 mg tablet administered orally once daily
Study NCT01370603 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ezetimibe
Description: 10 mg tablet administered orally once daily
Study NCT01370603 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ezetimibe/atorvastatin
Description: Ezetimibe/atorvastatin 10 mg/40 mg combination tablet administered orally once daily
Study NCT01370603 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to atorvastatin
Description: Administered orally once daily
Study NCT01370603 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to ezetimibe
Description: Administered orally once daily
Study NCT01370603 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo to ezetimibe/atorvastatin
Description: Administered orally once daily
Study NCT03643146 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Management
Description: Will use passive ubiquitous sensing through FitBit to 1)learn behavioral profiles of subjects who have pre-HTN/HTN and/or pre-diabetes /Diabetes 2) provide personalized recommendations through mobile based messaging app that will increase the likelihood of engaging in health diet/nutrition, physical activity and sleep practices
Study NCT03643146 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control Group
Description: will receive standard medical care where research assistant will give pamphlets, with one size fits all recommendations for diet/nutrition, physical activity and sleep, to 10 subjects with comorbid HTN and T2D.
Study NCT00136032 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Somatropin
Description: Stratified based on age and estrogen status from 3 to 6 mcg/kg/day
Study NCT00136032 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Dosage based on age and estrogen status ranging from 3 to 6 mcg/kg/day
Study NCT00467064 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Arthritis Quick Start
Description: Two week, lay led, workshop focusing on goal setting, problem solving, and content specific to disease management.
Study NCT00467064 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Delayed treatment intervention
Description: After four months delay, participants in Control Group receive Experimental workshop.
Study NCT00467064 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Delayed treatment intervention
Description: After four months delay, participants in Control Group receive Experimental workshop.
Study NCT03453827 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study NCT01420263 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Re-feeding residuals
Description: In the presence of significant gastric residuals (more than 1/3 of previous feed or > 2ml), residual volumes will be re-fed if the physician decision is to continue feeds as scheduled in the absence of other clinical signs and symptoms of feeding intolerance. This practice will be continued until full enteral feeding is achieved and maintained for a minimum of 48 hours.
Study NCT01420263 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fresh Feeding Breastmilk or Formula only
Description: In the presence of significant gastric residuals (more than 1/3 of previous feed or > 2ml), residual volumes will be discarded and fresh breastmilk or formula will be fed if the physician decision is to continue feeds as scheduled in the absence of other clinical signs and symptoms of feeding intolerance. This practice will be continued until full enteral feeding is achieved and maintained for a minimum of 48 hours.
Study NCT01393041 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Angio-Seal VIP
Description: Vascular Closure Device
Study NCT00192140 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: FluMist
Description: A single intranasal dose of FluMist will be administered to approx. 300 subjects.
Study NCT01207050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ramelteon
Description: 8mg capsule taken within one half hour of bedtime each night over the three night study period.
Study NCT01207050 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Control treatment
Study NCT04485650 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: music therapy
Description: The music were chosen by a researcher under guidance of an expert and grouped as relaxing, classical, mystical, and Turkish folk music. One of them was chosen by the patients following the application of spinal anesthesia in the music group.
Study NCT04485650 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: sedated group
Description: Sedation was performed to the sedated group after spinal anesthesia based on the height and weight data and the doctor's decision. The number of participants:30
Study NCT04485650 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: non-sedated group
Description: The patients in the non-sedated group were followed without any procedure (sedation and music). The number of participants:30
Study NCT00547911 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Droxidopa
Study NCT00547911 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbidopa
Study NCT00057304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO 205-2349
Study NCT00815815 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Structured Behavioral Treatment
Description: Daily therapy sessions and a weight gain protocol involving set meals and exercise levels
Study NCT00815815 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Structured Behavioral Treatment
Description: Daily therapy sessions and a weight gain protocol involving set meals and exercise levels
Study NCT00547911 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Entacapone
Study NCT01078662 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: olaparib
Description: Tablets Oral BID
Study NCT03363659 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disulfiram
Description: Disulfiram is taken orally, twice daily.
Study NCT03363659 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Copper gluconate
Description: Copper gluconate is taken orally, twice daily
Study NCT03363659 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Temozolomide is taken once daily
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Knowledge Alone
Description: Increase knowledge relate d STIs, STI risk, alcohol impairment, condom use skills, alcohol use behavior tracking skills, testing \& treatment services.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-efficacy alone
Description: Increase self-efficacy to us e protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Perceived benefits alone
Description: Increase perceived benefits to use protective behavioral strategies to reduce the negative consequences of engaging in sexual behaviors under the influence of alcohol.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Benefits and self-efficacy
Description: Increase perceived benefits to use protective behavioral strategies to reduce the negative consequences of engaging in sexual behaviors under the influence of alcohol and increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Injunctive norms alone
Description: Correct misperceptions regarding approval of alcohol misuse \& sexual risk taking.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Injunctive norms and self-efficacy
Description: Correct misperceptions regarding approval of alcohol misuse \& sexual risk taking and increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Injunctive norms and benefits
Description: Correct misperceptions regarding approval of alcohol misuse \& sexual risk taking and increase perceived benefits to use protective behavioral strategies to reduce the negative consequences of engaging in sexual behaviors under the influence of alcohol and increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Injunctive norms, benefits, self-efficacy
Description: Correct misperceptions regarding approval of alcohol misuse \& sexual risk taking; increase perceived benefits to use protective behavioral strategies to reduce the negative consequences of engaging in sexual behaviors under the influence of alcohol and increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex; and increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Descriptive norms alone
Description: Correct misperceptions of prevalence of alcohol-induced sexual risk behaviors, alcohol use/misuse, and sexual risk behaviors.
Study NCT03671109 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHA-PPQ)
Description: Following physical examination, recruited women with more than 13 weeks of gestational age will receive IPTp-DHA-PPQ under supervision
Study NCT03671109 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Following physical examination, recruited women with more than 13 weeks of gestational age will receive IPTp-Placebo under supervision
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Descriptive norms and self-efficacy
Description: Correct misperceptions of prevalence of alcohol-induced sexual risk behaviors, alcohol use/misuse, and sexual risk behaviors and increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Descriptive norms and perceived benefits
Description: Correct misperceptions of prevalence of alcohol-induced sexual risk behaviors, alcohol use/misuse, and sexual risk behaviors and increase perceived benefits to use protective behavioral strategies to reduce the negative consequences of engaging in sexual behaviors under the influence of alcohol.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Descriptive norms, benefits, self-efficacy
Description: Correct misperceptions of prevalence of alcohol-induced sexual risk behaviors, alcohol use/misuse, and sexual risk behaviors; increase perceived benefits to use protective behavioral strategies to reduce the negative consequences of engaging in sexual behaviors under the influence of alcohol; and increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Descriptive norms and injunctive norms
Description: Correct misperceptions of prevalence of alcohol-induced sexual risk behaviors, alcohol use/misuse, and sexual risk behaviors and correct misperceptions regarding approval of alcohol misuse \& sexual risk taking.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Descriptive and injunctive norms, self-efficacy
Description: orrect misperceptions of prevalence of alcohol-induced sexual risk behaviors, alcohol use/misuse, and sexual risk behaviors; correct misperceptions regarding approval of alcohol misuse \& sexual risk taking; and increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Descriptive and injunctive norms, and benefits
Description: Correct misperceptions of prevalence of alcohol-induced sexual risk behaviors, alcohol use/misuse, and sexual risk behaviors; correct misperceptions regarding approval of alcohol misuse \& sexual risk taking; and increase perceived benefits to use protective behavioral strategies to reduce the negative consequences of engaging in sexual behaviors under the influence of alcohol.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Descriptive & injunctive norms, benefits, efficacy
Description: Correct misperceptions of prevalence of alcohol-induced sexual risk behaviors, alcohol use/misuse, and sexual risk behaviors; correct misperceptions regarding approval of alcohol misuse \& sexual risk taking; increase perceived benefits to use protective behavioral strategies to reduce the negative consequences of engaging in sexual behaviors under the influence of alcohol; and Increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expectancies alone
Description: Decrease the expectation that alcohol is needed to have good sexual encounter.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expectancies and self-efficacy
Description: Decrease the expectation that alcohol is needed to have good sexual encounter and increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expectancies and perceived benefits
Description: Decrease the expectation that alcohol is needed to have good sexual encounter and increase perceived benefits to use protective behavioral strategies to reduce the negative consequences of engaging in sexual behaviors under the influence of alcohol.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expectancies, benefits, self-efficacy
Description: Decrease the expectation that alcohol is needed to have good sexual encounter; increase perceived benefits to use protective behavioral strategies to reduce the negative consequences of engaging in sexual behaviors under the influence of alcohol; and increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expectancies and injunctive norms
Description: Decrease the expectation that alcohol is needed to have good sexual encounter and correct misperceptions regarding approval of alcohol misuse \& sexual risk taking.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expectancies, injunctive norms, self-efficacy
Description: Decrease the expectation that alcohol is needed to have good sexual encounter; correct misperceptions regarding approval of alcohol misuse \& sexual risk taking; and increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expectancies, injunctive norms, and benefits
Description: Decrease the expectation that alcohol is needed to have good sexual encounter; correct misperceptions regarding approval of alcohol misuse \& sexual risk taking; and increase perceived benefits to use protective behavioral strategies to reduce the negative consequences of engaging in sexual behaviors under the influence of alcohol.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expectancies, injunctive norms, benefits, efficacy
Description: Decrease the expectation that alcohol is needed to have good sexual encounter; correct misperceptions regarding approval of alcohol misuse \& sexual risk taking; increase perceived benefits to use protective behavioral strategies to reduce the negative consequences of engaging in sexual behaviors under the influence of alcohol; and increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expectancies and descriptive norms
Description: Decrease the expectation that alcohol is needed to have good sexual encounter and correct misperceptions of prevalence of alcohol-induced sexual risk behaviors, alcohol use/misuse, and sexual risk behaviors.
Study NCT03408743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expectancies, descriptive norms, & self-efficacy
Description: Decrease the expectation that alcohol is needed to have good sexual encounter; correct misperceptions of prevalence of alcohol-induced sexual risk behaviors, alcohol use/misuse, and sexual risk behaviors; and increase self-efficacy to use protective behavioral strategies (e.g., condom negotiation skills) to reduce unprotected sex.